MDCXWMedicus Pharma Ltd.
0.3216USD+3.74%Mkt Cap: —P/E: —4d ago
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatme…
Industry Peers
Financial Services$1.09TUSDP/E 12.8
$1.09TUSDP/E 12.8
$929.49BUSDP/E 15.0
$691.41BUSDP/E 31.3
$495.16BUSDP/E 31.1
$403.69BUSDP/E 13.3
$348.54BUSDP/E 14.5
$318.17BUSDP/E 16.4
$281.37BUSDP/E 14.4
$281.45BUSDP/E 17.9
$286.79BUSDP/E 17.9
$274.28BUSDP/E 14.5
$260.43BUSDP/E 12.5
$260.35BUSDP/E 15.2
$221.04BUSDP/E 14.2
$210.40BUSDP/E 18.9
$197.51BUSDP/E 14.2
$207.62BUSDP/E 14.0
$204.62BUSDP/E 18.4
$200.44BUSDP/E 18.2
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-35.44M $
Revenue/Share—
Last Price0.3216 USD
Fiscal Year End—
MR Quarter—
Employees16
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-10.69
EPS (TTM)—
EPS (Forward)—
52W Range
0.31003% of range0.6795
52W High0.6795 USD
52W Low0.3100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE52467.97%
ROA-352.28%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.78M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt6.46M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-81.08
Current Ratio1.57
Quick Ratio1.40
Book Value/Sh-0.0290 USD
Cash/Share0.2400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float52.61M
Insiders—
Institutions—
Technical
SMA 502.500 (-87.1%)
SMA 2002.500 (-87.1%)
Beta-0.48
S&P 52W Chg15.75%
Avg Vol (30d)222
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—